Stock Financial Ratios


ITCI / Intra-Cellular Therapies Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price16.17
Volume949,500.00
Market Cap ($M)665.26
Enterprise Value ($M)652.74
Book Value ($M)375.50
Book Value / Share8.68
Price / Book2.08
NCAV ($M)378.37
NCAV / Share8.75
Price / NCAV2.18
Income Statement (mra) ($M)
Revenue0.33
EBITDA-118.26
Net Income-116.43
Balance Sheet (mrq) ($M)
Cash & Equivalents52.34
Cash / Share1.21
Assets334.19
Liabilities14.75
Quick Ratio36.86
Current Ratio36.86
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.31
Return on Assets (ROA)-0.30
Return on Equity (ROE)-0.31
Identifiers and Descriptors
CUSIP46116X101
Central Index Key (CIK)1567514
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
46116X901
46116X951
Share Statistics
Common Shares Outstanding (M)54.58
Scoring Models
Piotroski F Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Equity Per Share7.39
Retained Earnings Per Share-8.72
Inventory Work In Progress Per Share0.00
Liabilities And Stock Equity Per Share7.73
Long Term Debt Per Share0.00
Liabilities Per Share0.34
Treasury Stock Per Share0.00
Accounts Payable Per Share0.00
Debt Per Share0.00
Inventory Per Share0.00
Assets Current Per Share7.71
Property Plant And Equipment Gross Per Share0.08
Cash Per Share1.21
Assets Per Share7.73
Liabilities Current Per Share0.27
Assets Other Non Current Per Share0.00
Intangibles Per Share0.00
Property Plant And Equipment Per Share0.02
Additional Paid In Capital Per Share16.11
Goodwill Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Accounts Receivable Per Share0.00
Inventory Raw Materials Per Share0.00
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.06
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Property Plant And Equipment Net Per Share0.02
Cash And Equivalents Per Share1.21
Minority Interest Per Share0.00

Related News Stories

Biotech Forum Daily Digest: What Now For Sarepta?

5h seekingalpha
Biotech fell to begin the holiday shortened trading week, continuing a bout of poor performance in the fourth quarter of this year. (143-1)

Your Daily Pharma Scoop: Roche Rallies, Alnylam Granted BTD, Celsion Soars

7h seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (166-1)

Intra-Cellular Therapies' (ITCI) CEO Sharon Mates on Q3 2017 Results - Earnings Call Transcript

2017-11-08 seekingalpha
Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies' Third Quarter 2017 Financial Results Conference Call. As a reminder, today's conference call is being recorded. We will have a question-and-answer session later and the instructions will be given at that time. [Operator Instructions]

Your Daily Pharma Scoop: Teva Q3 Results, Boost For RedHill, Clovis Reports Rubraca Sales

2017-11-02 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Please click here or scroll down below to read an important announcement about changes and additions to the daily scoop. (685-3)

Your Daily Pharma Scoop: Synergy Must Buy, RedHill Positive Data, CTMX-AMGN Collaboration

2017-10-04 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (866-17)

CUSIP: 46116X101